[ Tue, Aug 06th 2024 ]: WOPRAI
[ Tue, Aug 06th 2024 ]: WOPRAI
[ Tue, Aug 06th 2024 ]: WOPRAI
[ Tue, Aug 06th 2024 ]: WOPRAI
[ Tue, Aug 06th 2024 ]: WOPRAI
[ Tue, Aug 06th 2024 ]: WOPRAI
[ Tue, Aug 06th 2024 ]: WOPRAI
[ Tue, Aug 06th 2024 ]: WOPRAI
[ Tue, Aug 06th 2024 ]: WOPRAI
[ Tue, Aug 06th 2024 ]: WOPRAI
[ Tue, Aug 06th 2024 ]: WOPRAI
[ Tue, Aug 06th 2024 ]: WOPRAI
[ Tue, Aug 06th 2024 ]: WOPRAI
[ Tue, Aug 06th 2024 ]: WOPRAI
[ Tue, Aug 06th 2024 ]: WOPRAI
[ Tue, Aug 06th 2024 ]: WOPRAI
[ Tue, Aug 06th 2024 ]: WOPRAI
[ Tue, Aug 06th 2024 ]: WOPRAI
[ Tue, Aug 06th 2024 ]: WOPRAI
[ Tue, Aug 06th 2024 ]: WOPRAI
[ Tue, Aug 06th 2024 ]: WOPRAI
[ Tue, Aug 06th 2024 ]: WOPRAI
[ Tue, Aug 06th 2024 ]: WOPRAI
[ Tue, Aug 06th 2024 ]: WOPRAI
[ Tue, Aug 06th 2024 ]: WOPRAI
[ Tue, Aug 06th 2024 ]: WOPRAI
[ Tue, Aug 06th 2024 ]: WOPRAI
[ Tue, Aug 06th 2024 ]: WOPRAI
[ Tue, Aug 06th 2024 ]: WOPRAI
[ Tue, Aug 06th 2024 ]: WOPRAI
[ Tue, Aug 06th 2024 ]: WOPRAI
[ Tue, Aug 06th 2024 ]: WOPRAI
[ Tue, Aug 06th 2024 ]: WOPRAI
[ Tue, Aug 06th 2024 ]: WOPRAI
[ Tue, Aug 06th 2024 ]: WOPRAI
[ Tue, Aug 06th 2024 ]: WOPRAI
[ Tue, Aug 06th 2024 ]: WOPRAI
[ Tue, Aug 06th 2024 ]: WOPRAI
[ Tue, Aug 06th 2024 ]: WOPRAI
[ Tue, Aug 06th 2024 ]: WOPRAI
[ Tue, Aug 06th 2024 ]: WOPRAI
[ Tue, Aug 06th 2024 ]: WOPRAI
[ Tue, Aug 06th 2024 ]: WOPRAI
[ Tue, Aug 06th 2024 ]: WOPRAI
[ Tue, Aug 06th 2024 ]: WOPRAI
[ Tue, Aug 06th 2024 ]: WOPRAI
[ Tue, Aug 06th 2024 ]: WOPRAI
[ Tue, Aug 06th 2024 ]: WOPRAI
Brian Abrahams Reiterated (BCRX) at Buy and Held Target at $10 on, Aug 6th, 2024
- 🞛 This publication is a summary or evaluation of another publication
Brian Abrahams of RBC Capital, Reiterated "BioCryst Pharmaceuticals, Inc." (BCRX) at Buy and Held Target at $10 on, Aug 6th, 2024.
Brian has made no other calls on BCRX in the last 4 months.
There is 1 other peer that has a rating on BCRX. Out of the 1 peers that are also analyzing BCRX, 0 agree with Brian's Rating of Hold.
This is the rating of the analyst that currently disagrees with Brian
- Serge Belanger of "Needham" Reiterated at Strong Buy and Held Target at $12 on, Tuesday, May 7th, 2024